Evidence map›Paper›PMID 19393989›Full record

Trial reportBiological psychiatry2009

Reward processing after catecholamine depletion in unmedicated, remitted subjects with major depressive disorder.

Gregor Hasler, David A Luckenbaugh, Joseph Snow, Noah Meyers, Tracy Waldeck, Marilla Geraci, Jonathan Roiser, Brian Knutson, Dennis S Charney, Wayne C Drevets

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Biological psychiatry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Dietary tyrosine/phenylalanine depletion effects on behavioral and brain signatures of human motivational processing.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Trial
  4. Trial
  5. Dopamine-related deficit in reward learning after catecholamine depletion in unmedicated, remitted subjects with bulimia nervosa.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Trial
  6. Trial
  7. Review
  8. Diminished differentiation of rewards in individuals at clinical high-risk for psychosis.European archives of psychiatry and clinical neuroscience · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Neural Correlates of Impaired Reward-Effort Integration in Remitted Bulimia Nervosa.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Gregor HaslerDepartment of Psychiatry, University Hospital, Culmannstrasse 8 8091, Zurich, Switzerland. g.hasler@bluewin.ch
David A Luckenbaugh
Joseph Snow
Noah Meyers
Tracy Waldeck
Marilla Geraci
Jonathan Roiser
Brian Knutson
Dennis S Charney
Wayne C Drevets
National Institute of Mental Health · USNational Institutes of Health · USIcahn School of Medicine at Mount Sinai · USStanford University · USUniversity Hospital of Zurich · CH

Funding

Psychiatry Consultation Liaison Service ResearchZIAMH002922 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI PAO, MARYLAND · 2009 to 2025
$11.5M
Functional MRI Study of Brain Mechanisms Mediating Anhedonia in Major DepressionZIAMH002812 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI DREVETS, WAYNE C · 2009 to 2009
$754k
Functional Neuroimaging In Unipolar And Bipolar Depressed PatientsZIAMH002792 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI DREVETS, WAYNE C · 2009 to 2009
$376k
Intramural NIH HHS Z99 MH999999
6 · The paper itself

Abstract

backgroundWe investigated whether performance on a reward processing task differs between fully remitted patients with major depressive disorder (MDD) and healthy control subjects after catecholamine depletion.

methodsSeventeen unmedicated subjects with remitted MDD (RMDD) and 13 healthy control subjects underwent catecholamine depletion with oral alpha-methyl-para-tyrosine (AMPT) in a randomized, placebo-controlled, double-blind crossover study. The main outcome measure was the reaction time on the monetary incentive delay (MID) task.

resultsA diagnosis x drug interaction was evident (p = .001), which was attributable to an increase in reaction time across all incentive levels after AMPT in RMDD subjects (p = .001) but no significant AMPT effect on reaction time in control subjects (p = .17). There was no drug x diagnosis interaction on control tasks involving working memory or attention. In the RMDD sample the AMPT-induced depressive symptoms correlated with AMPT-induced changes in reaction time at all incentive levels of the MID task (r values = .58-.82, p < .002).

conclusionsUnder catecholamine depletion the RMDD subjects were robustly differentiated from control subjects by development of performance deficits on a reward processing task. These performance deficits correlated directly with the return of depressive symptoms after AMPT administration. The sensitivity of central reward processing systems to reductions in brain catecholamine levels thus seems to represent a trait-like marker in MDD.

Indexed as

RewardAdolescentAdultAmphetamineCatecholaminesCentral Nervous System StimulantsCross-Over StudiesDouble-Blind MethodFemaleHumansLinear ModelsMajor Depressive DisorderMaleMiddle AgedNeuropsychological TestsPsychiatric Status Rating ScalesAmphetamineCatecholaminesCentral Nervous System Stimulants

Identifiers

PMID19393989
PMCPMC3073352
OpenAlexW2088396706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.